SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?


To: Joe Dancy who wrote (373)12/23/1997 10:21:00 PM
From: JakeSki  Respond to of 696
 
I am going to wait a bit longer and look for a bottom to form. I don't see it yet - stellar FA not withstanding.

-- GeorgeP



To: Joe Dancy who wrote (373)12/24/1997 1:33:00 AM
From: milton  Respond to of 696
 
Joe Dancy
Thanks for the lead. The bargains are appearing everywhere. It's like a post Xmas sale before the holidays. My only problem is to where to put my money. No way can we lose on these bargains in the long term (12 months).



To: Joe Dancy who wrote (373)12/27/1997 9:46:00 PM
From: Joe Dancy  Read Replies (3) | Respond to of 696
 
Well our Lone Star Growth Investor website was mentioned in the Chicago Tribune on 12/24 - and in our portfolio analysis BIOI has the best growth to PE ratio - one of the major tools we use to select stocks, in addition to the solid underlying value price/book, no debt, etc.

I made UroCor (UCOR) our latest Model Portfolio selection - it reminds me so much of BIOI right down to the price (around $6.50) - no debt, price/book 1.3, market cap $65 million, estimated growth rate long term > 30%, analyst composite rating a buy. The write up on UCOR is at members.aol.com if anyone has an interest. I really like this company as a "twin sister" to BIOI.

Also noticed in Barron's today that 90% of mutual funds are lagging the S&P 500 this year. Glad I'm not in that business -g-

Best - Joe